Scientific Output

1.

Attard G, A’Hern R, Swennenhuis JF, Reid AHM, Olmos D, Vickers E, Levink R, Coumans F, Moreira J, Riisnaes R, Carden CP, Oomen NB, Hawche G, Jameson C, Thompson E, Sipkema R, Parker C, Dearnaley D, Kaye SB, Cooper CS, Molina A, Cox ME, Leon MW Terstappen LWMM, de Bono JS. Molecular Characterization of Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer. Cancer Research In Press.

2.

Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LWMM, Meropol NJ. Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer Annals of Oncology In Press.

3.

J. Wind, J.B. Tuynman, A.G.J. Tibbe, J.F. Swennenhuis, D.J. Richel, M.I. van Berge Henegouwen, W.A. Bemelman Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood EJCO 2009

4.

D Olmos, HT Arkenau, JE Ang, I Ledaki, G Attard, CP Carden, AHM Reid, RA Hem, PC Fong, NB Oomen, R Molife, D Dearnaley, C Parker, LWWM Terstappen, JS DeBono. Circulating Tumor Cells (CTC) as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Annals of Oncology August 11, 2008. [Epub ahead of print]

5.

X Li, C Breukers, A Ymeti, B Lunter, LWMM. Terstappen, J Greve. CD4 and CD8 Enumeration for HIV Monitoring in Resource-Constrained Settings. Cytometry Part B 2008 Sep 29. [Epub ahead of print]

6.

Olmos D, Arkenau HT, Ang JE, Ledaki I, Attard G, Carden CP, Reid AHM, Hem RA, Fong PC, Oomen NB, Molife R, Dearnaley D, Parker C, Terstappen LWWM, DeBono JS. Circulating Tumor Cells (CTC) as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Annals of Oncology 20: 27-37,2009.

7.

Li X, Breukers C, Ymeti A, Lunter B, Terstappen LWMM., Greve J. CD4 and CD8 Enumeration for HIV Monitoring in Resource-Constrained Settings. Cytometry 76B: 118-126, 2009.

8.

Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LWMM, Meropol NJ. Prognostic Significance of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer Annals of Oncology 20: 1223-1229, 2009.

9.

Attard G, Swennenhuis JF, Olmos D, Reid AHM, Vickers E, A’Hern R, Levink R, Coumans F, Moreira J, Riisnaes R, Oomen NB, Hawche G, Jameson C, Thompson E, Sipkema R, Carden CP, Parker C, Dearnaley D, Kaye SB, Cooper CS, Molina A, Cox ME, Terstappen LWMM, de Bono JS. Characterization of ERG, AR and PTEN status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer. Cancer Research 69: 2912-2918, 2009.

10.

Swennenhuis JF, Tibbe AGJ, Levink R, Sipkema RCJ, Terstappen LWMM. Characterization of Circulating Tumor Cells by Fluorescence In-Situ Hybridization. Cytometry Part A 75A: 520-527, 2009.

11.

Connelly M, Wang Y, Doyle GV, Terstappen L, McCormack R. Commentary The molecular characterization of 19 breast cancer cell lines by Sieuwerts et al. JNCI, 101: 895, 2009.

12.

Miller MC, Gerald V Doyle GV, Leon WMM Terstappen LWMM. Significance of Circulating Tumor Cells detected by the CellSearch® System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncology Vol 2010, Article ID 617421, 1-8, 2009.

13.

Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Gualberto A. Safety, Pharmacokinetics and Pharmacodynamics of the IGF-IR Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin. Journal of Thoracic Oncology 4(11), 1397-1403, 2009.

14.

Pully, V.V. Lenferink, A., Otto, C., (2010) Hybrid Rayleigh-, Raman and TPE fluorescence spectral confocal microscopy of living cells. Acc. by JRS aug 2009

15.

Manen, H.W.J. van, Otto, C., (2009) Cholesterol esters are detected by Raman microspectroscopy in HeLa cells, Journal of Raman Spectroscopy, 40(2), p.117-118.

16.

Chimento, P. Jurna, M., Korterik, J., Otto, C., Herek, J., Offerhaus, H.L. (2009) High resolution narrowband CARS spectroscopy in the spectral fingerprint region”. Journal of Raman Spectroscopy DOI 10.1002/jrs.2267

17.

Escalante-Marun, M., Blum, C., Cesa, Y. Otto, C., Subramaniam, V. (2009) “FRET-pair printing of fluorescent proteins”, Langmuir 25(12), p. 7019-7024

18.

Murade, C.U., Subramaniam, V., Otto, C., Bennink, M.L., (2009) “Interaction of oxazole yellow dyes with DNA studied with hybrid optical tweezers and fluorescence microscopy” Biophysical Journal 97, p. 835-843.

19.

Pully, V.V., Otto, C. (2009) “The Intensity of the 1602 cm-1-band in Human Cells is related to Mitochondrial Activity” Journal of Raman Spectroscopy, 40(5), p. 473-475.

20.

Jurna, M. Korterik, J.P., Otto, C., Herek, J.L., Offerhaus, H.L. (2009) “Vibrational Phase Contrast Microscopy by use of Coherent anti-Stokes Raman Scattering” Physical Review Letters, 103, 043905.

21.

Wu, C.C., Xu, H., Otto, C., Reinhoudt, D.N., Lammertink, R.G.H., Huskens, J., Subramaniam, V., Velders, A.H. (2009) “Porous multi-layer-coated AFM tips for Dip-Pen Nanolithography of proteins”, JACS Communications 131, p. 7526-7527

22.

Vaandrager, B., Testerink, N., Ajat, M., Houweling, M., Brouwers, J.F.H.M., Pully, V.V., van Manen, H.W.J., Otto, C., Helms, J.B. (2009) Raman imaging and lipidomic analysis of lipid droplets in activated hepatic stellate cells. Chem. And Phys. Of lipids 160S, S1 – S17

23.

Blum, C., Mosk, A., Otto, C., Vos, W., Subramaniam, V., (2009) Spectral emission imaging to map photonic properties below the crystal surface of 3D photonic crystals. JOSA B, 26(11), 2101 - 2108